Two Chinese pharma companies, which supplied 5.5 lakh rapid testing kits for COVID-19 to India, said they are ready to cooperate with Indian agencies looking into allegations of poor accuracy of their products. The Indian Council of Medical Research had earlier advised states to stop using the rapid antibody test kits for two days till it examines their quality.
NASA has developed VITAL (Ventilator Intervention Technology Accessible Locally), a high-pressure ventilator in 37 days to treat COVID-19 patients. The device is composed of far fewer parts, many of which are available to potential manufacturers, NASA said. "Its flexible design means it can be modified for use in hospitals being set up in hotels and other high- capacity facilities," NASA added.
Comments
Post a Comment